Literature DB >> 19921092

Predictors of a better outcome of pneumatic dilatation in patients with primary achalasia.

Yuriko Tanaka1, Katsuhiko Iwakiri, Noriyuki Kawami, Hirohito Sano, Mariko Umezawa, Makoto Kotoyori, Yoshio Hoshihara, Tsutomu Nomura, Masao Miyashita, Choitsu Sakamoto.   

Abstract

OBJECTIVE: Pneumatic dilatation (PD) has been widely used in the treatment of primary achalasia. The aim of this study was to evaluate the effectiveness of PD and its predictive factors in Japanese patients with primary achalasia.
METHODS: Fifty-five consecutive patients were treated using PD (Rigiflex balloon dilator). Diagnosis was established through radiographic and/or esophageal manometry. All patients underwent a pre-designed clinical evaluation prior to and 6 months after PD treatment. We defined success of PD as 6 months or more of clinical remission, with a total score (0-4) <or=2, a decrease in the total score >or=1 and the score for each item <or=1. Possible predictive factors to response were analyzed.
RESULTS: Successful PD was achieved in 41 of 55 (74.5%) patients. The median age (58.0 years) in the successful group was significantly older than in the failure group (37.5 years), but there were no differences in other factors between the groups. When the cut-off value was set at 40 years of age, the success rate of PD in the >40-year age group was 85.7%, while the <40-year age group achieved a rate of only 38.5%. Multivariate logistic regression analysis also demonstrated that older age was the only independent factor associated with the success of PD. There was no perforation related to PD.
CONCLUSIONS: PD is a safe and effective treatment for achalasia, particularly in older patients who experience a better outcome than younger patients.

Entities:  

Mesh:

Year:  2010        PMID: 19921092     DOI: 10.1007/s00535-009-0145-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  19 in total

1.  Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors.

Authors:  A Staiano; R E Clouse
Journal:  Am J Gastroenterol       Date:  2001-12       Impact factor: 10.864

Review 2.  Motor disorders of the esophagus.

Authors:  S Cohen
Journal:  N Engl J Med       Date:  1979-07-26       Impact factor: 91.245

3.  The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia.

Authors:  Marcelo F Vela; Joel E Richter; Farah Khandwala; Eugene H Blackstone; Don Wachsberger; Mark E Baker; Thomas W Rice
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05       Impact factor: 11.382

4.  Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia.

Authors:  Frank Zerbib; Valérie Thétiot; Frédérique Richy; Dafr-Allah Benajah; Laurent Message; Hervé Lamouliatte
Journal:  Am J Gastroenterol       Date:  2006-04       Impact factor: 10.864

5.  A prospective assessment of gastroesophageal reflux before and after treatment of achalasia patients: pneumatic dilation versus transthoracic limited myotomy.

Authors:  J P Shoenut; D Duerksen; C S Yaffe
Journal:  Am J Gastroenterol       Date:  1997-07       Impact factor: 10.864

6.  Long-term effects of pneumatic dilatation on symptoms and lower oesophageal sphincter pressure in achalasia.

Authors:  R Penagini; P Cantù; M Mangano; P Colombo; P A Bianchi
Journal:  Scand J Gastroenterol       Date:  2002-04       Impact factor: 2.423

7.  Long-term outcome of pneumatic dilation in the treatment of achalasia.

Authors:  Georgios Karamanolis; Spiros Sgouros; Georgios Karatzias; Efthimia Papadopoulou; Konstantinos Vasiliadis; Gerasimos Stefanidis; Apostolos Mantides
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

Review 8.  Current therapies for achalasia: comparison and efficacy.

Authors:  M F Vaezi; J E Richter
Journal:  J Clin Gastroenterol       Date:  1998-07       Impact factor: 3.062

9.  Predictors of outcome of pneumatic dilation in achalasia.

Authors:  Kaveh Farhoomand; Jason T Connor; Joel E Richter; Edgar Achkar; Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2004-05       Impact factor: 11.382

10.  Pneumatic dilation in achalasia with a low-compliance balloon: results of a 5-year prospective evaluation.

Authors:  T Wehrmann; V Jacobi; M Jung; B Lembcke; W F Caspary
Journal:  Gastrointest Endosc       Date:  1995-07       Impact factor: 9.427

View more
  14 in total

Review 1.  Current status in the treatment options for esophageal achalasia.

Authors:  Seng-Kee Chuah; Chien-Hua Chiu; Wei-Chen Tai; Jyong-Hong Lee; Hung-I Lu; Chi-Sin Changchien; Ping-Huei Tseng; Keng-Liang Wu
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Possible new endoscopic finding in patients with achalasia: "Gingko leaf sign".

Authors:  Yoshimasa Hoshikawa; Shintaro Hoshino; Noriyuki Kawami; Tomohide Tanabe; Yuriko Hanada; Nana Takenouchi; Osamu Goto; Mitsuru Kaise; Katsuhiko Iwakiri
Journal:  Esophagus       Date:  2019-06-21       Impact factor: 4.230

Review 3.  2011 update on esophageal achalasia.

Authors:  Seng-Kee Chuah; Pin-I Hsu; Keng-Liang Wu; Deng-Chyang Wu; Wei-Chen Tai; Chi-Sin Changchien
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

Review 4.  Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature.

Authors:  Kristle L Lynch; John E Pandolfino; Colin W Howden; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2012-10-02       Impact factor: 10.864

5.  Peroral endoscopic myotomy for esophageal achalasia: outcomes of the first over 100 patients with short-term follow-up.

Authors:  Hironari Shiwaku; Haruhiro Inoue; Kanefumi Yamashita; Toshihiro Ohmiya; Richiko Beppu; Ryo Nakashima; Shinsuke Takeno; Takamitsu Sasaki; Satoshi Nimura; Yuichi Yamashita
Journal:  Surg Endosc       Date:  2016-03-01       Impact factor: 4.584

6.  For patients with primary achalasia the clinical success of pneumatic balloon dilatation can be predicted from the residual fraction of radionuclide during esophageal transit scintigraphy.

Authors:  Han Ho Jeon; Young Hoon Youn; Kwangwon Rhee; Jie-Hyun Kim; Hyojin Park; Jeffrey L Conklin
Journal:  Dig Dis Sci       Date:  2013-10-29       Impact factor: 3.199

7.  Can achalasia subtyping by high-resolution manometry predict the therapeutic outcome of pneumatic balloon dilatation?

Authors:  Young-Eun Joo
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

8.  A review of factors predicting outcome of pneumatic dilation in patients with achalasia cardia.

Authors:  Uday C Ghoshal; Murali Rangan
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

9.  Peroral endoscopic myotomy (POEM) vs pneumatic dilation (PD) in treatment of achalasia: A meta-analysis of studies with ≥ 12-month follow-up.

Authors:  Andrew Ofosu; Babu P Mohan; Yervant Ichkhanian; Maen Masadeh; John Febin; Mohamed Barakat; Daryl Ramai; Saurabh Chandan; Gulara Haiyeva; Shahab R Khan; Mohamad Aghaie Meybodi; Antonio Facciorusso; Alessandro Repici; Sachin Wani; Nirav Thosani; Mouen A Khashab
Journal:  Endosc Int Open       Date:  2021-06-21

10.  Safety and efficacy of botulinum toxin injection therapy for esophageal achalasia in Japan.

Authors:  Daisuke Yamaguchi; Nanae Tsuruoka; Yasuhisa Sakata; Ryo Shimoda; Kazuma Fujimoto; Ryuichi Iwakiri
Journal:  J Clin Biochem Nutr       Date:  2015-10-17       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.